Back to
DRIEHAUS CAPITAL MANAGEMENT LLC
CYTK19 quarters
Position history for
DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in CYTOKINETICS INC
No. Driehaus Capital Management exited its CYTK (Cytokinetics) position in Q1 2024. Its Q4 2023 13F listed 220,384 shares worth $18.4M. Driehaus Capital Management first reported CYTK in Q2 2019 and held it in 17 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$24.6M
Total Shares Change
-2.2M
Quarter-by-Quarter History
Other major holders of CYTK: BlackRock, Inc., BlackRock Finance, Inc., FMR LLC